FDA updates guidance for Reconsideration
This guidance provides procedures for ANDA applicants who wish to pursue a request for reconsideration
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
